142 related articles for article (PubMed ID: 1262787)
1. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
Ballet JJ; Insel R; Merler E; Rosen FS
J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
[TBL] [Abstract][Full Text] [Related]
2. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine deaminase in lymphocyte proliferation.
Hovi T; Smyth JF; Allison AC; Williams SC
Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
[TBL] [Abstract][Full Text] [Related]
4. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
5. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
Cha S
Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
[No Abstract] [Full Text] [Related]
6. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
Kotb M; Veit BC
Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
[No Abstract] [Full Text] [Related]
7. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
8. Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.
Cha S; Agarwal RP; Parks RE
Biochem Pharmacol; 1975 Dec; 24(23):2187-97. PubMed ID: 1212267
[No Abstract] [Full Text] [Related]
9. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
10. Study on the inhibition of adenosine deaminase.
Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
[TBL] [Abstract][Full Text] [Related]
11. Adenosine and guanosine metabolism during phytohemagglutinin induced transformation of human lymphocytes.
Snyder FF; Mendelsohn J; Seegmiller JE
Adv Exp Med Biol; 1977; 76A():441-7. PubMed ID: 404852
[No Abstract] [Full Text] [Related]
12. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
[TBL] [Abstract][Full Text] [Related]
15. The effects of ADA inhibition on B cell differentiation in the rat.
Barton RW
Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
[No Abstract] [Full Text] [Related]
16. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
[TBL] [Abstract][Full Text] [Related]
17. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
18. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
Nicholson JK; Gordon DS; McDougal JS
Cell Immunol; 1983 Jul; 79(2):320-33. PubMed ID: 6347398
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin.
Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):287-94. PubMed ID: 6476984
[TBL] [Abstract][Full Text] [Related]
20. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
